EMJ Neurology 13 [Supplement 3] 2025

EMJ Neurology 13 [Supplement 3] . 2025

February 2025

The annual Clinical Trials in Alzheimer’s Disease (CTAD) Congress brings together global experts to discuss developments in Alzheimer’s disease (AD) clinical research and showcase researchers’ work on AD trials. This article describes a recently initiated Phase II trial of a novel anti-tau monoclonal antibody, BMS-986446, the design for which was presented at the 17^th CTAD Congress in Madrid, Spain, on 31^st October 2024.

Long-Term Patient Outcomes: The Role of Sustained Treatment Efficacy in Myasthenia Gravis

There have been great advances in the field of generalised myasthenia gravis (gMG) in recent years, but many patients remain dissatisfied… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

Tackling Infectious Diseases

This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain. Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

The Unspeakable Disease: A Tale of Two Siblings

The deficiency of arylsulfatase A due to the mutations in the ARSA gene is the cause of a rare inherited lysosomal storage disease… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

Understanding Developmental and Epileptic Encephalopathies

Developmental and epileptic encephalopathy (DEE) refers to a collection of rare and severe epilepsies that feature both seizures and… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

EMJ Neurology 13 [Supplement 3] . 2025

In this issue

Long-Term Patient Outcomes: The Role of Sustained Treatment Efficacy in Myasthenia Gravis

Tackling Infectious Diseases

The Unspeakable Disease: A Tale of Two Siblings

Understanding Developmental and Epileptic Encephalopathies

Therapy Area

About Us

EMJ Neurology 13 [Supplement 3] . 2025

In this issue

Latest articles

Long-Term Patient Outcomes: The Role of Sustained Treatment Efficacy in Myasthenia Gravis

Tackling Infectious Diseases

The Unspeakable Disease: A Tale of Two Siblings

Understanding Developmental and Epileptic Encephalopathies